Clinical Trial Update: Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chidamide in combination with linperlisib for refractory/relapsed follicular lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Linperlisib (linperlisib)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Follicular Lymphoma, Refractory B-Cell Lymphoma | Phase 2 | Status: RECRUITING